We can't find the internet
Attempting to reconnect
Something went wrong!
Attempting to reconnect
Access AI content by logging in
In this episode, we break down Trump's proposed "Most Favored Nation" model for drug pricing, how it ties U.S. prices to international benchmarks, and where it stands legally and politically. We explain what it could mean for AstraZeneca's portfolio and pricing in the U.S., along with potential implementation hurdles and industry pushback.
Get the top 40+ AI Models for $20 at AI Box: https://aibox.ai